Studies on PAKs in gliomas showed that PAK1 and PAK4 play an important role in the occurrence and development of GBM, and the abnormal activation of PAK1 is even more prominent [1, 43, 47]. This evidence concerns the gene PAK4 and central nervous system cancer.